clinical trial · NCT07314346
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Healthy Volunteer StudyBuprenorphine/Naloxone + BEM/RZRMethadone +BEM/RZR
brief summary
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
started
Jan 7, 2025
primary completion
Jun 1, 2026
completion
Jun 1, 2026
last updated
Apr 13, 2026
official title
A Phase 1, Open-Label, Two-Part, Single-Sequence Study to Evaluate the Effect of Multiple Oral Doses of BEM/RZR FDC on the Pharmacokinetics of Buprenorphine/Naloxone or Methadone in Participants on Stable Maintenance Therapy for Opiate Withdrawal
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol